financetom
Business
financetom
/
Business
/
Procter & Gamble Unusual Options Activity
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Procter & Gamble Unusual Options Activity
Aug 29, 2025 11:28 AM

Investors with a lot of money to spend have taken a bullish stance on Procter & Gamble ( PG ) .

And retail traders should know.

We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.

Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with PG, it often means somebody knows something is about to happen.

Today, Benzinga's options scanner spotted 10 options trades for Procter & Gamble ( PG ).

This isn't normal.

The overall sentiment of these big-money traders is split between 50% bullish and 30%, bearish.

Out of all of the options we uncovered, there was 1 put, for a total amount of $27,160, and 9, calls, for a total amount of $660,860.

Expected Price Movements

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $135.0 to $170.0 for Procter & Gamble ( PG ) during the past quarter.

Analyzing Volume & Open Interest

Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Procter & Gamble's ( PG ) options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Procter & Gamble's ( PG ) whale trades within a strike price range from $135.0 to $170.0 in the last 30 days.

Procter & Gamble Option Volume And Open Interest Over Last 30 Days

Largest Options Trades Observed:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume
PG CALL TRADE BULLISH 10/17/25 $1.64 $1.6 $1.63 $165.00 $198.6K 4.9K 1.3K
PG CALL TRADE NEUTRAL 09/19/25 $3.65 $3.45 $3.55 $155.00 $106.5K 2.1K 300
PG CALL SWEEP BULLISH 09/19/25 $1.3 $1.17 $1.29 $160.00 $64.4K 8.1K 573
PG CALL SWEEP NEUTRAL 10/10/25 $7.1 $4.8 $5.54 $155.00 $60.7K 0 100
PG CALL SWEEP BULLISH 09/12/25 $1.15 $0.94 $0.95 $160.00 $58.7K 1.0K 642

About Procter & Gamble

Since its founding in 1837, Procter & Gamble ( PG ) has become one of the world's largest consumer product manufacturers, with annual sales approaching $85 billion. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent just more than half of the firm's consolidated total.

Having examined the options trading patterns of Procter & Gamble ( PG ), our attention now turns directly to the company. This shift allows us to delve into its present market position and performance

Present Market Standing of Procter & Gamble

Currently trading with a volume of 2,251,284, the PG's price is up by 0.93%, now at $157.09.

RSI readings suggest the stock is currently may be approaching overbought.

Anticipated earnings release is in 49 days.

Expert Opinions on Procter & Gamble

Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $170.5.

Unusual Options Activity Detected: Smart Money on the Move

Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.

* An analyst from BNP Paribas downgraded its action to Outperform with a price target of $177.

* Maintaining their stance, an analyst from Barclays continues to hold a Equal-Weight rating for Procter & Gamble ( PG ), targeting a price of $164.

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Procter & Gamble ( PG ) options trades with real-time alerts from Benzinga Pro.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US FDA staff questions confirmatory trial data for Intercept's liver disease drug
US FDA staff questions confirmatory trial data for Intercept's liver disease drug
Sep 11, 2024
Sept 11 (Reuters) - Staff reviewers at the U.S. Food and Drug Administration said on Wednesday a confirmatory trial did not show the effectiveness of Intercept's liver disease drug, which received the health regulator's accelerated nod in 2016. Under the accelerated pathway, companies are required to conduct additional trials to establish their drug's benefits. Failure to do so can sometimes...
--One Liberty Properties Maintains Dividend at $0.45 per Share; Payable Oct. 2 to Holders of Record on Sept. 24
--One Liberty Properties Maintains Dividend at $0.45 per Share; Payable Oct. 2 to Holders of Record on Sept. 24
Sep 11, 2024
10:48 AM EDT, 09/11/2024 (MT Newswires) -- Price: 26.54, Change: -0.47, Percent Change: -1.74 ...
US Postal Service to end discounted rates for package consolidators
US Postal Service to end discounted rates for package consolidators
Sep 11, 2024
WASHINGTON (Reuters) - The U.S. Postal Service said Wednesday it will no longer offer discounted rates for packages entered by consolidators, part of a wide ranging effort to modernize its network. USPS said it is entering new contracts with package consolidator companies that consolidate large volumes of packages for entry into various points of the network saying the prior contracts...
PharmAla Edging Higher As Contracted to Supply Johns Hopkins Medicine for Clinical Trial
PharmAla Edging Higher As Contracted to Supply Johns Hopkins Medicine for Clinical Trial
Sep 11, 2024
10:49 AM EDT, 09/11/2024 (MT Newswires) -- PharmAla Biotech Holdings ( MDXXF ) , in the research and manufacture of LaNeo MDMA and novel derivatives of MDMA (MDXX class molecules), reported Wednesday that it has been contracted as a supplier of MDMA to a clinical trial at Johns Hopkins Medicine. We're looking forward to continuing to provide exceptional service -...
Copyright 2023-2026 - www.financetom.com All Rights Reserved